Apparent Life-Threatening Event in an Infant with SARS-CoV-2 Infection.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
24 May 2021
Historique:
pubmed: 2 10 2020
medline: 3 6 2021
entrez: 1 10 2020
Statut: ppublish

Résumé

The 2019 novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a global outbreak of infection. In general, children with coronavirus disease-2019 have been reported to show milder respiratory symptoms than adult patients. Here, we have described a case of a SARS-CoV-2-infected infant who presented to our hospital with a severe episode of an apparent life-threatening event (ALTE). An 8-month-old, otherwise healthy female infant presented to our hospital because of a sudden cardiopulmonary arrest. Approximately 1 h before this episode, the patient showed no symptoms, except a worse humor than usual. On arrival at our hospital, the patient had severe acidosis, but there were no clear signs of inflammatory response. Chest computed tomography showed weak consolidations in the upper right lung and atelectasis in the lower left lung. No signs of congenital heart disease or cardiomyopathy were observed on echocardiography, and no significant arrhythmia was observed during the clinical course. However, SARS-CoV-2 RNA was detected by real-time reverse transcription polymerase chain reaction in tracheal aspirate and urine samples. Although the assessment of further similar cases is indispensable, this case suggests that SARS-CoV-2 infection may be an underlying factor in the pathophysiology of ALTE.

Identifiants

pubmed: 32999184
doi: 10.7883/yoken.JJID.2020.572
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-239

Auteurs

Fumikazu Sano (F)

Department of Pediatrics, University of Yamanashi, Japan.

Hideaki Yagasaki (H)

Department of Pediatrics, University of Yamanashi, Japan.

Satoru Kojika (S)

Department of Pediatrics, University of Yamanashi, Japan.

Takako Toda (T)

Department of Pediatrics, University of Yamanashi, Japan.

Yosuke Kono (Y)

Department of Pediatrics, University of Yamanashi, Japan.

Katsue Suzuki-Inoue (K)

Department of Clinical and Laboratory Medicine, University of Yamanashi, Japan.

Tomoyuki Sasaki (T)

Department of Clinical and Laboratory Medicine, University of Yamanashi, Japan.

Shinji Ogihara (S)

Department of Laboratory, University of Yamanashi, Japan.

Towa Matsuno (T)

Department of Laboratory, University of Yamanashi, Japan.

Osamu Inoue (O)

Division of Infection Control and Prevention, University of Yamanashi, Japan.

Takeshi Moriguchi (T)

Department of Emergency and Critical Care Medicine, University of Yamanashi, Japan.

Norikazu Harii (N)

Department of Community and Family Medicine, University of Yamanashi, Japan.

Junko Goto (J)

Department of Emergency and Critical Care Medicine, University of Yamanashi, Japan.

Tatsuya Shimizu (T)

Department of Radiology, University of Yamanashi, Japan.

Takeshi Inukai (T)

Department of Pediatrics, University of Yamanashi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH